Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.
about
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature ReviewMolecular phenotypes of colorectal cancer and potential clinical applicationsDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologymTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors.The molecular background of mucinous carcinoma beyond MUC2Oncogenic mutations of PIK3CA in human cancersPI3K pathway alterations in cancer: variations on a themePIK3CA gene mutations in Northwest Chinese esophageal squamous cell carcinomaThe analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type.Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors.Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterationsPTEN loss induces epithelial--mesenchymal transition in human colon cancer cells.Microsatellite instability in colorectal cancer-the stable evidence.PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.PIK3CA mutations predict recurrence in localized microsatellite stable colon cancerPIK3CA Amplification Is Common in Left Side-Tubular Adenomas but Uncommon Sessile Serrated Adenomas Exclusively with KRAS Mutation.PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal CancerPredictive value of K-ras and PIK3CA in non-small cell lung cancer patients treated with EGFR-TKIs: a systemic review and meta-analysis.c-Met inhibitor synergizes with tumor necrosis factor-related apoptosis-induced ligand to induce papillary thyroid carcinoma cell deathPI3K expression and PIK3CA mutations are related to colorectal cancer metastases.Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway.PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.Prognostic impact of mutation profiling in patients with stage II and III colon cancerPIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancerNo association between phosphatase and tensin homolog genetic polymorphisms and colon cancerPredictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.Prevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patients.Pharmacogenomics of cetuximab in metastatic colorectal carcinoma.Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress.Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer.High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.PIK3CA mutation and methylation influences the outcome of colorectal cancerKRAS and TP53 mutations in colorectal carcinoma.Oncogenic PIK3CA mutations in colorectal cancers and polyps.Kernel differential subgraph reveals dynamic changes in biomolecular networks.Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers.Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphoma.
P2860
Q24289005-865CB9D2-75DA-436A-909B-1DD04C2982ECQ26785725-E0AD9967-5220-441A-AF10-26256D31B97FQ27011884-5ADECC38-43A5-4B41-B0AD-9DB52E878A1DQ27851707-241F1CFE-0534-44BE-AF18-B121224EC9F5Q28083904-A4C0B43A-093E-4857-8E82-18C3E709679FQ28284802-A4FB6447-1E93-4FA1-959D-E8C0B2B9B568Q29615530-8E8243A3-4498-4C74-93A3-C0C8F4E78922Q33572680-B07933EB-01ED-41D5-9B9E-2F37976044B9Q33833156-63B59E7E-A7BB-4C3B-B180-538A51CFA4F4Q33865287-CA1774EB-509E-4ABD-BEA0-EAB90B90C190Q34068205-6287EC6D-6F86-46E3-982D-A7DD40237BEDQ34100984-CD146354-8CD8-4ECB-A78B-B7C6DCC1D6EAQ34616565-47DD4997-D532-429C-8B17-D3C378FF8702Q34778710-30BCC511-1E77-4953-8AAF-0CF8831BCBA9Q35236785-8C282F04-9955-414A-AC59-004A99C522A2Q35651134-DDC278E4-C28E-4E4A-BC8A-9D6365B9BC7FQ35815544-949135BB-6888-4C54-812A-7836AE6BB467Q35824117-7FA40552-7318-4923-A5BA-355722162AD1Q35872516-DEC36F49-CBB6-4DF0-ADBA-CF4BD0569BFEQ36121260-09CB1B71-7BBA-49B6-B0EA-0A4DA0E2B228Q36182284-48999856-87D7-42CF-8DC7-1A50618E764CQ36661711-6A4ED2D2-3C4A-47BC-BB9F-AA6DE0C3BDA5Q36796320-DC16AC5C-90B8-460B-B1FA-19B50794D5BCQ37137091-0B56006F-8E53-42D1-A8FB-03B8604E66FDQ37304241-0477DEC3-7776-4E0F-B798-7D41A30A0F7CQ37360360-DE17C895-946A-4699-8049-0FD24287B7CEQ37370000-7D68EA4D-6501-4FC2-A0BB-9379F63BD421Q37525272-D55CDC4C-9F23-4CB9-A5D9-2EE8CA6EAC3FQ37589226-78F8AE8E-FC08-417B-9ED9-AD514F570BBAQ38269777-DFBA9EA5-1C36-43E1-ABF2-A619190FC1C4Q38353227-F4DFD216-8459-462A-BB79-B5949636597BQ38946538-A1AE7FAC-5159-4630-A9DD-4CEB6E3903FCQ39820073-3A1A2617-D61B-4E9B-B110-3B913A828877Q39843538-54080CC5-B967-424E-B01B-8FDFDE7D6310Q41850443-BA13DC75-F43D-4706-BF4F-B6D78077B7F1Q42362550-5684C9F4-74D9-4E7B-941A-7B2DC7EA87A5Q44836946-8D33F6FA-AAFD-490C-8E72-B71F8A864ED1Q47215648-83E98367-9194-449B-AB66-BE5BEDB1D866Q48084362-7C32562A-5453-47F5-9506-91394A42A953Q53173084-43D7875B-1BC2-4D3B-A7DD-B1EABA46066B
P2860
Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Clinicopathological analysis o ...... in Middle Eastern population.
@en
type
label
Clinicopathological analysis o ...... in Middle Eastern population.
@en
prefLabel
Clinicopathological analysis o ...... in Middle Eastern population.
@en
P2093
P356
P1433
P1476
Clinicopathological analysis o ...... in Middle Eastern population.
@en
P2093
A Abduljabbar
F Al-Dayel
J Abubaker
K S Al-Kuraya
L H Ashari
N Al-Sanea
S Al-Harbi
P2888
P304
P356
10.1038/SJ.ONC.1211013
P407
P577
2008-01-14T00:00:00Z
P5875
P6179
1024866931